BOSS update: Oesophageal cancer with Massimil...

Endoscopist and pancreatologist Livia Archibugi joins Jörn Schattenberg to review the hepato-pancreato-biliary highlights of UEG Week 2026: same-session EUS-ERCP, peppermint oil after bile duct stone clearance, celecoxib in acute pancreatitis, GLP-1 receptor agonists before endos ...  Show more

Mary Phillips and ESGENA President Deepa Gandhi review UEG Week 2026 from a nursing and allied health perspective. They cover the second victim phenomenon, bile duct injury, nurse-led research on remote capsule endoscopy and endoscopy workload, long-term outcomes after acute panc ...  Show more

Send us Fan MailIn this episode, we review the clinical presentation, screening guidelines, diagnosis and management of Barrett's Esophagus - one of the risk factors for developing Esophageal Adenocarcinoma. In our medicine minute, we discuss a landmark trial that transitioned tr ...  Show more

In this episode, Michael and Josh take a dive into the world of driver mutations, looking at two of the most clinically consequential: EGFR and ALK mutations. The work done in these areas has led to treatments that represent incredible advances over chemotherapy. How incredible? ...  Show more

Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he de ...  Show more